Volgen
Ekkehard Beck
Ekkehard Beck
GlaxoSmithKline Vaccines
Geverifieerd e-mailadres voor u.northwestern.edu
Titel
Geciteerd door
Geciteerd door
Jaar
Systematic review of invasive meningococcal disease: sequelae and quality of life impact on patients and their caregivers
KJ Olbrich, D Müller, S Schumacher, E Beck, K Meszaros, F Koerber
Infectious diseases and therapy 7, 421-438, 2018
1462018
A Data-Driven Simulation of HIV Spread Among Young Men Who Have Sex With Men: Role of Age and Race Mixing and STIs
EC Beck, M Birkett, B Armbruster, B Mustanski
JAIDS Journal of Acquired Immune Deficiency Syndromes 70 (2), 186-194, 2015
652015
Cost-effectiveness of 4CMenB infant vaccination in England: a comprehensive valuation considering the broad impact of serogroup B invasive meningococcal disease
E Beck, J Klint, M Neine, S Garcia, K Meszaros
Value in Health 24 (1), 91-104, 2021
262021
Elementary proof of convergence to the mean-field model for the SIR process
B Armbruster, E Beck
Journal of mathematical biology 75, 327-339, 2017
262017
Systematic Literature Review and Quantitative Analysis of Health Problems Associated with Sexually Transmitted Neisseria gonorrhoeae Infection
J Whelan, J Eeuwijk, E Bunge, E Beck
Infectious Diseases and Therapy 10, 1887-1905, 2021
192021
Resource management and process change in a simplified model of the emergency department
E Beck, H Balasubramanian, PL Henneman
Proceedings of the 2009 Winter Simulation Conference (WSC), 1887-1895, 2009
192009
An elementary proof of convergence to the mean-field equations for an epidemic model
B Armbruster, E Beck
IMA Journal of Applied Mathematics 82 (1), 152-157, 2017
182017
Vaccine market access pathways in the EU27 and the United Kingdom− analysis and recommendations for improvements
V Laigle, MJ Postma, M Pavlovic, C Cadeddu, E Beck, A Kapusniak, ...
Vaccine 39 (39), 5706-5718, 2021
152021
Risk factors for cervical cancer in women in China: A meta-model
S Aballéa, E Beck, X Cheng, N Demarteau, X Li, F Ma, M Neine, FH Zhao
Women's Health 16, 1745506520940875, 2020
152020
Capturing the value of vaccination within health technology assessment and health economics: Literature review and novel conceptual framework
E Beck, E Biundo, N Devlin, TM Doherty, AJ Garcia-Ruiz, M Postma, ...
Vaccine 40 (30), 4008-4016, 2022
142022
Capturing the value of vaccination within health technology assessment and health economics: Country analysis and priority value concepts
M Postma, E Biundo, A Chicoye, N Devlin, TM Doherty, AJ Garcia-Ruiz, ...
Vaccine 40 (30), 3999-4007, 2022
142022
The potential public health impact of adolescent 4CMenB vaccination on Neisseria gonorrhoeae infection in England: a modelling study
KJ Looker, R Booton, N Begum, E Beck, J Shen, KME Turner, ...
BMC Public Health 23 (1), 1, 2023
132023
Healthcare resource consumption and cost of invasive meningococcal disease in France: a study of the National Health Insurance Database
C Weil-Olivier, MK Taha, C Emery, S Bouée, E Beck, E Aris, ...
Infectious diseases and therapy 10 (3), 1607-1623, 2021
132021
Modelling the impact of 4CMenB and MenACWY meningococcal combined vaccination strategies including potential 4CMenB cross-protection: An application to England
E Beck, J Klint, S Garcia, V Abbing, V Abitbol, O Akerborg, L Argante, ...
Vaccine 38 (47), 7558-7568, 2020
112020
Care pathways in invasive meningococcal disease: a retrospective analysis of the French national public health insurance database
C Weil-Olivier, MK Taha, S Bouée, C Emery, V Loncle-Provot, ...
Human vaccines & immunotherapeutics 18 (1), 2021764, 2022
102022
Long-term mortality and state financial support in invasive meningococcal disease—real-world data analysis using the French national claims database (SNIIRAM)
J Shen, S Bouée, E Aris, C Emery, EC Beck
Infectious Diseases and Therapy, 1-13, 2022
102022
A discrete event simulation approach to resource management, process changes and task prioritization in emergency departments
EC Beck
72009
The potential clinical impact and cost-effectiveness of the updated COVID-19 mRNA Fall 2023 vaccines in the United States
MA Kohli, M Maschio, K Joshi, A Lee, K Fust, E Beck, N Van de Velde, ...
Journal of Medical Economics 26 (1), 1532-1545, 2023
62023
Public Health Impact and Cost-Effectiveness Analysis of Routine Infant 4CMenB Vaccination in Germany to Prevent Serogroup B Invasive Meningococcal Disease
S Scholz, M Schwarz, E Beck, K Meszaros, M Schneider, B Ultsch, ...
Infectious Diseases and Therapy, 1-21, 2022
62022
PIN43 LIFECYCLE-MODEL-BASED ECONOMIC EVALUATION OF INFANT MENINGITIS B VACCINATION IN THE UK
J Sevilla, D Tortorice, D Kantor, DE Bloom, C Hogea, E Beck
Value in Health 22, S647, 2019
62019
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20